Biotech Alert: Searches spiking for these stocks today
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Exicure (XCUR),… To see the...
Author : The Fly
Morning Movers: Target tumbles following earnings release
Check out this morning’s top movers from around Wall Street, compiled by The Fly. HIGHER – Comcast (CMCSA)… To see the rest of the story go...
Jefferies ‘bullish’ on Meta Platforms hiring Clara Shih from Salesforce
After Clara Shih, former Salesforce (CRM) CEO of AI, announced in a Linkedin post yesterday that she will lead a “new Business AI group” at...
Citi downgrades Target to Neutral after ‘very poor results’
Citi analyst Paul Lejuez downgraded Target (TGT) to Neutral from Buy with a price target of $130, down from $188. Although the company’s Q3 “may...
Pfizer selects Chris Boshoff as chief scientific officer, WSJ reports
Pfizer has named Chris Boshoff, who has led the company’s cancer research and marketing for more than a year, as its chief scientific officer, effective...
Netflix price target raised by $175 at Pivotal Research, here’s why
Pivotal Research raised the firm’s price target on Netflix to $1,100 from $925 and keeps a Buy rating on the shares. Post the “(mostly) successful”...
Lemonade just upgraded at Morgan Stanley, here’s why
Morgan Stanley upgraded Lemonade to Equal Weight from Underweight with a price target of $42, up from $23, following the investor day. Lemonade “charted an...
Toast just downgraded at Exane BNP Paribas, here’s why
Exane BNP Paribas downgraded Toast to Neutral from Outperform with a $37 price target. The firm cites valuation for the downgrade with the shares having...
Closing Bell Movers: Keysight up 9% after Q4 earnings beat
Check out this evening’s top movers from around Wall Street, compiled by The Fly. HIGHER AFTER EARNINGS… To see the rest of the story go...
Keefe downgrades Fannie, Freddie on dilution risk from privatization
Keefe Bruyette downgraded both Fannie Mae (FNMA) and Freddie Mac (FMCC) to Market Perform from Outperform with increased price targets of $3 and $4, respectively....